A review of activity indices and efficacy Endpoints for clinical trials of medical therapy in adults with Crohn's disease

被引：584

作者：

Sandborn, WJ

Feagan, BG

Hanauer, SB

Lochs, H

Löfberg, R

Modigliani, R

Present, DH

Rutgeerts, P

Schölmerich, J

Stange, EF

Sutherland, LR

机构：

[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

[2] Univ Western Ontario, London, ON, Canada

[3] Univ Chicago, Chicago, IL 60637 USA

[4] Univ Berlin, Klinikum Charite, Schwerpunkt Gastroenterol Hepatol & Endokrinol, Berlin, Germany

[5] Huddinge Univ Hosp, S-14186 Huddinge, Sweden

[6] Hop St Louis, Paris, France

[7] CUNY Mt Sinai Sch Med, New York, NY 10029 USA

[8] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium

[9] Univ Regensburg, D-8400 Regensburg, Germany

[10] Robert Bosch Krankenhaus, Stuttgart, Germany

[11] Dept Community Hlth Sci, Calgary, AB, Canada

来源：

GASTROENTEROLOGY | 2002年 / 122卷 / 02期

关键词：

D O I：

10.1053/gast.2002.31072

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：512 / 530

页数：19

共 115 条

[11] Oral budesonide is as effective as oral prednisolone in active Crohn's disease [J].

Campieri, M ;

Ferguson, A ;

Doe, W ;

Persson, T ;

Nilsson, LG ;

Malchow, H ;

Prantera, C ;

Mani, V ;

OMorain, C ;

Selby, W ;

Pallone, F ;

diPietralata, MM ;

Sjodahl, R ;

Florin, T ;

Smith, P ;

Bianchi, P ;

Lofberg, R ;

Rutgeerts, P ;

Smallwood, R ;

Lamers, HW ;

TasmanJones, C ;

Hunter, JO ;

Hodgson, H ;

Danielsson, A ;

Lee, FI ;

Piacitelli, G ;

Giovanni, S ;

Ellis, A ;

Weir, DG .

GUT, 1997, 41 (02) :209-214

[12] A CONTROLLED DOUBLE-BLIND-STUDY OF AZATHIOPRINE IN THE MANAGEMENT OF CROHNS-DISEASE [J].

CANDY, S ;

WRIGHT, J ;

GERBER, M ;

ADAMS, G ;

GERIG, M ;

GOODMAN, R .

GUT, 1995, 37 (05) :674-678

[13]

CAPRILLI R, 1994, ALIMENT PHARM THER, V8, P35

[14] CORRELATIONS BETWEEN CLINICAL ACTIVITY, ENDOSCOPIC SEVERITY, AND BIOLOGICAL PARAMETERS IN COLONIC OR ILEOCOLONIC CROHNS-DISEASE - A PROSPECTIVE MULTICENTER STUDY OF 121 CASES [J].

CELLIER, C ;

SAHMOUD, T ;

FROGUEL, E ;

ADENIS, A ;

BELAICHE, J ;

BRETAGNE, JF ;

FLORENT, C ;

BOUVRY, M ;

MARY, JY ;

MODIGLIANI, R ;

COLOMBEL, JF ;

CORTOT, A ;

LESCUT, D ;

BITOUN, A ;

LEMANN, M ;

SALMERON, M ;

THEROND, JP ;

VERNISSE, B ;

SEE, A ;

RAOUL, JL .

GUT, 1994, 35 (02) :231-235

[15] Perceptual responses in patients with inflammatory and functional bowel disease [J].

Chang, L ;

Munakata, J ;

Mayer, EA ;

Schmulson, MJ ;

Johnson, TD ;

Bernstein, CN ;

Saba, L ;

Naliboff, B ;

Anton, PA ;

Matin, K .

GUT, 2000, 47 (04) :497-505

[16] PATIENTS WITH IRRITABLE-BOWEL-SYNDROME HAVE GREATER PAIN TOLERANCE THAN NORMAL SUBJECTS [J].

COOK, IJ ;

VANEEDEN, A ;

COLLINS, SM .

GASTROENTEROLOGY, 1987, 93 (04) :727-733

[17] Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease [J].

Cortot, A ;

Colombel, JF ;

Rutgeerts, P ;

Lauritsen, K ;

Malchow, H ;

Hämling, J ;

Winter, T ;

Van Gossum, A ;

Persson, T ;

Pettersson, E .

GUT, 2001, 48 (02) :186-190

[18] Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial [J].

D'Haens, G ;

Van Deventer, S ;

Van Hogezand, R ;

Chalmers, D ;

Kothe, C ;

Baert, F ;

Braakman, T ;

Schaible, T ;

Geboes, K ;

Rutgeerts, P .

GASTROENTEROLOGY, 1999, 116 (05) :1029-1034

[19] Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine [J].

D'Haens, G ;

Geboes, K ;

Rutgeerts, P .

GASTROINTESTINAL ENDOSCOPY, 1999, 50 (05) :667-671

[20] Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum [J].

D'Haens, GR ;

Geboes, K ;

Peeters, M ;

Baert, F ;

Pennickx, F ;

Rutgeerts, P .

GASTROENTEROLOGY, 1998, 114 (02) :262-267

← 1 2 3 4 5 6 7 8 9 10 →